Latest News

  • RESEARCH

    27 Feb 2026

    Can Big Data Crack the Brain’s Toughest Diseases?
  • MARKET TRENDS

    19 Feb 2026

    AI Multi-Omics Meets Market Reality Check
  • RESEARCH

    13 Feb 2026

    AI and Multi-Omics Join Forces to Rethink Drug Discovery
  • INNOVATION

    11 Feb 2026

    NVIDIA Pushes AI Into the Heart of Drug Discovery

Takeda Turns to AI to Reshape Early Drug Discovery

Researchers in a pharmaceutical lab working with automated drug discovery equipment

INVESTMENT

9 Feb 2026

Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research

Robotic laboratory arm handling scientific glassware in a research lab

RESEARCH

27 Feb 2026

Can Big Data Crack the Brain’s Toughest Diseases?

Valinor and Renew join forces to build a vast AI-ready neurology dataset, hoping to sharpen drug discovery for Alzheimer’s, Parkinson’s, a...

Laboratory test tubes filled with liquid during scientific analysis

MARKET TRENDS

19 Feb 2026

AI Multi-Omics Meets Market Reality Check

AI-powered multi-omics is reshaping drug discovery, but business models and market claims demand a closer look

Laboratory researcher using pipette for multi omics drug discovery analysis

RESEARCH

13 Feb 2026

AI and Multi-Omics Join Forces to Rethink Drug Discovery

Athos and Xeptiva use AI-powered multi-omics to sharpen drug discovery and reduce costly development risks

NVIDIA headquarters sign reflecting AI expansion into drug discovery

INNOVATION

11 Feb 2026

NVIDIA Pushes AI Into the Heart of Drug Discovery

BioNeMo links AI models with lab testing, aiming to speed drug research and cut costs through closer industry collaboration

Researchers in a pharmaceutical lab working with automated drug discovery equipment

INVESTMENT

9 Feb 2026

Takeda Turns to AI to Reshape Early Drug Discovery

Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research

Large pharmaceutical production facility with Eli Lilly branding

MARKET TRENDS

5 Feb 2026

The Great AI Land Grab in Pharma

Drugmakers race to lock in AI partners, cut risk, and secure a lead in data-driven discovery

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.